A*STAR Infectious Diseases Labs (A*STAR IDL)
Three stars of scientific vision
20 Jan 2026Whether combating global viral threats or advancing next-generation telecommunications, the A*STAR winners of the 2025 President’s Science and Technology Awards showcase the talent and drive at the foundations of world-class research excellence.
Driving science to new horizons
19 Nov 2025In recognition of their research excellence, leadership and impact both locally and globally, ten leading A*STAR researchers have been awarded the A*STAR Distinguished Fellowship and Fellowships.
Mucus impossible: Giving nasal vaccines a new ride
24 Oct 2025A new ‘liquid lipid’ approach that penetrates the nose’s mucus barrier could lead to needle-free, nasal spray-based mRNA vaccines.
Powering the changemakers
24 Jul 2025This year, the National Research Foundation Singapore is empowering three A*STAR researchers to push the boundaries of science.
Deconstructing the esophagus cell by cell
3 Mar 2025Researchers uncovered how specialised stem cells act as building blocks for the esophagus, shaping its development and offering insights into treating related diseases.
Immune crosstalk fuels viral flames
5 Feb 2025A*STAR researchers find that ordinary communications between immune cells during chikungunya virus infection can drive joint inflammation seen in the disease.
Pathways to Impact
30 Dec 2024Through its focus on attracting, developing and retaining talents in science and technology, A*STAR is helping to build a rich national ecosystem of research, innovation and enterprise.
Reinforcing frontline defences against variants
14 Nov 2024Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the need for COVID-19 vaccines that target these antibody responses.
Virus killers get under the skin
10 May 2024Research suggests monitoring individuals previously infected with Zika virus for chronic skin diseases caused by overactive T cells.
Mixed shots hit a moving target
19 Jan 2024While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.
Shielding seniors from a crowned killer
8 Dec 2023A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the COVID-19 vaccine.
What’s behind the rise of mpox?
12 Jul 2023Scientists survey how the mpox virus spreads through populations, the immunology of infections and current treatment interventions.